Selenium and Arsenic Pharmacodynamics

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 10, 2015

Primary Completion Date

December 19, 2016

Study Completion Date

January 19, 2017

Conditions
Arsenic Poisoning Chronic
Interventions
DIETARY_SUPPLEMENT

Anhydrous selenite

40 volunteer sufferers will be housed in a local private in-patient clinic where they will follow a fixed, communal diet consisting of drinking water and meals from their village. On a 6th day we will give a single dose of placebo (sodium chloride) or anhydrous sodium selenite (0.8mg selenium) labelled with a non-radioactive naturally occurring isotope (77Se), to distinguish it from selenium already in the body.

DIETARY_SUPPLEMENT

Sodium chloride

40 volunteer sufferers will be housed in a local private in-patient clinic where they will follow a fixed, communal diet consisting of drinking water and meals from their village. On a 6th day we will give a single dose of placebo (sodium chloride) or anhydrous sodium selenite (0.8mg selenium) labelled with a non-radioactive naturally occurring isotope (77Se), to distinguish it from selenium already in the body.

Trial Locations (1)

3570

Unity Hospital Pvt LTD, Lākshām

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

University of Calgary

OTHER

collaborator

University of Alberta

OTHER

collaborator

Emory University

OTHER

collaborator

Wagner College, Staten Island, NY, USA

UNKNOWN

collaborator

Applied Speciation and Consulting LLC, WA, USA

UNKNOWN

lead

University of Saskatchewan

OTHER

NCT02377635 - Selenium and Arsenic Pharmacodynamics | Biotech Hunter | Biotech Hunter